MétaCan
Menu
Back to cohort
Record W2152124092 · doi:10.1200/jco.2013.48.7934

International Myeloma Working Group Consensus Statement for the Management, Treatment, and Supportive Care of Patients With Myeloma Not Eligible for Standard Autologous Stem-Cell Transplantation

2014· review· en· W2152124092 on OpenAlexfundno aff
Antonio Palumbo, S. Vincent Rajkumar, Jesús F. San Miguel, Alessandra Larocca, Rubén Niesvizky, Gareth J. Morgan, Ola Landgren, Roman Hájek, Hermann Einsele, Kenneth C. Anderson, Meletios Α. Dimopoulos, Paul G. Richardson, Michèle Cavo, Andrew Spencer, A. Keith Stewart, Kazuyuki Shimizu, Sagar Lonial, Pieter Sonneveld, Brian G.M. Durie, Philippe Moreau, Robert Z. Orlowski

Bibliographic record

VenueJournal of Clinical Oncology · 2014
Typereview
Languageen
FieldMedicine
TopicMultiple Myeloma Research and Treatments
Canadian institutionsnot available
FundersCilagOnyx PharmaceuticalsNational University Health SystemNagoya City UniversityGil Medical Center, Gachon UniversityGenentechSahlgrenska UniversitetssjukhusetUniversità degli Studi di PaviaKeio UniversityCedars-Sinai Medical CenterWeill Cornell Medical CollegeAbbott LaboratoriesQueen Mary University of LondonUniversity of PittsburghAnkara UniversitesiUniversity of Arkansas for Medical SciencesArray BioPharmaTel Aviv UniversityGachon UniversityYork UniversityNorthwestern UniversityEmory UniversityAmerican Society of Clinical OncologyUniversität WienCelgeneDaiichi Sankyo EuropeNational Cancer InstituteGilead SciencesNational and Kapodistrian University of AthensKarolinska InstitutetMemorial Sloan-Kettering Cancer CenterBristol-Myers SquibbDaiichi-SankyoTakeda OncologyMassachusetts General HospitalSanofiAmgen
KeywordsMedicineMultiple myelomaIntensive care medicineTransplantationAdverse effectLenalidomideDiseaseAnemiaAutologous stem-cell transplantationConcomitantInternal medicineSurgery

Abstract

fetched live from OpenAlex

PURPOSE: To provide an update on recent advances in the management of patients with multiple myeloma who are not eligible for autologous stem-cell transplantation. METHODS: A comprehensive review of the literature on diagnostic criteria is provided, and treatment options and management of adverse events are summarized. RESULTS: Patients with symptomatic disease and organ damage (ie, hypercalcemia, renal failure, anemia, or bone lesions) require immediate treatment. The International Staging System and chromosomal abnormalities identify high- and standard-risk patients. Proteasome inhibitors, immunomodulatory drugs, corticosteroids, and alkylating agents are the most active agents. The presence of concomitant diseases, frailty, or disability should be assessed and, if present, treated with reduced-dose approaches. Bone disease, renal damage, hematologic toxicities, infections, thromboembolism, and peripheral neuropathy are the most frequent disabling events requiring prompt and active supportive care. CONCLUSION: These recommendations will help clinicians ensure the most appropriate care for patients with myeloma in everyday clinical practice.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.010
metaresearch head score (Gemma)0.009
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.010
Threshold uncertainty score0.051

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0100.009
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0030.002
Bibliometrics0.0040.004
Science and technology studies0.0010.001
Scholarly communication0.0010.001
Open science0.0040.002
Research integrity0.0030.004
Insufficient payload (model declined to judge)0.0020.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.134
GPT teacher head0.476
Teacher spread0.342 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations384
Published2014
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical OncologySame topicMultiple Myeloma Research and TreatmentsFrench-language works237,207